Average Co-Inventor Count = 6.11
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (14 from 3,684 patents)
2. Astrazeneca Ab (2 from 1,500 patents)
3. Bristol-myers Squibb Holdings Ireland (0 patent)
16 patents:
1. 9453039 - Crystal structures of SGLT2 inhibitors and processes for preparing same
2. 8802715 - Crystal forms of saxagliptin and processes for preparing same
3. 8680103 - Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
4. 8501698 - Crystal structures of SGLT2 inhibitors and processes for preparing same
5. 8242270 - Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
6. 8236847 - Crystal forms of saxagliptin and processes for preparing same
7. 7943656 - Crystal forms of saxagliptin and processes for preparing same
8. 7919598 - Crystal structures of SGLT2 inhibitors and processes for preparing same
9. 7491725 - Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
10. 7388096 - Crystalline forms of a factor Xa inhibitor
11. 7241899 - Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B
12. 7153879 - Polymorphs of an epothilone analog
13. 6982276 - Polymorphs of an epothilone analog
14. 6858644 - Paclitaxel solvates
15. 6689802 - Polymorphs of an epothilone analog